These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35744792)

  • 41. Analyses of the presence of mutations in Dystrophin protein to predict their relative influences in the onset of Duchenne Muscular Dystrophy.
    Bhattacharya S; Das A; Dasgupta R; Bagchi A
    Cell Signal; 2014 Dec; 26(12):2857-64. PubMed ID: 25220406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A
    Echigoya Y; Trieu N; Duddy W; Moulton HM; Yin H; Partridge TA; Hoffman EP; Kornegay JN; Rohret FA; Rogers CS; Yokota T
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials.
    Anthony K; Cirak S; Torelli S; Tasca G; Feng L; Arechavala-Gomeza V; Armaroli A; Guglieri M; Straathof CS; Verschuuren JJ; Aartsma-Rus A; Helderman-van den Enden P; Bushby K; Straub V; Sewry C; Ferlini A; Ricci E; Morgan JE; Muntoni F
    Brain; 2011 Dec; 134(Pt 12):3547-59. PubMed ID: 22102647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.
    Kinali M; Arechavala-Gomeza V; Feng L; Cirak S; Hunt D; Adkin C; Guglieri M; Ashton E; Abbs S; Nihoyannopoulos P; Garralda ME; Rutherford M; McCulley C; Popplewell L; Graham IR; Dickson G; Wood MJ; Wells DJ; Wilton SD; Kole R; Straub V; Bushby K; Sewry C; Morgan JE; Muntoni F
    Lancet Neurol; 2009 Oct; 8(10):918-28. PubMed ID: 19713152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Duchenne Muscular Dystrophy: From Diagnosis to Therapy.
    Falzarano MS; Scotton C; Passarelli C; Ferlini A
    Molecules; 2015 Oct; 20(10):18168-84. PubMed ID: 26457695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic polymorphism in muscle biopsies of Duchenne and Becker muscular dystrophy patients.
    Anand A; Prabhakar S; Kaul D
    Neurol India; 1999 Sep; 47(3):218-23. PubMed ID: 10514583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Live-imaging of revertant and therapeutically restored dystrophin in the Dmd
    Petkova MV; Stantzou A; Morin A; Petrova O; Morales-Gonzalez S; Seifert F; Bellec-Dyevre J; Manoliu T; Goyenvalle A; Garcia L; Richard I; Laplace-Builhé C; Schuelke M; Amthor H
    Neuropathol Appl Neurobiol; 2020 Oct; 46(6):602-614. PubMed ID: 32573804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the
    Potter RA; Griffin DA; Heller KN; Peterson EL; Clark EK; Mendell JR; Rodino-Klapac LR
    Hum Gene Ther; 2021 Apr; 32(7-8):375-389. PubMed ID: 33397205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
    den Dunnen JT; de Visser M; Bakker E
    Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic analysis of dystrophin gene for affected male and female carriers with Duchenne/Becker muscular dystrophy in Korea.
    Lee BL; Nam SH; Lee JH; Ki CS; Lee M; Lee J
    J Korean Med Sci; 2012 Mar; 27(3):274-80. PubMed ID: 22379338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community.
    Elhawary NA; Jiffri EH; Jambi S; Mufti AH; Dannoun A; Kordi H; Khogeer A; Jiffri OH; Elhawary AN; Tayeb MT
    Hum Genomics; 2018 Apr; 12(1):18. PubMed ID: 29631625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system.
    Kudoh H; Ikeda H; Kakitani M; Ueda A; Hayasaka M; Tomizuka K; Hanaoka K
    Biochem Biophys Res Commun; 2005 Mar; 328(2):507-16. PubMed ID: 15694376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy.
    Hrach HC; Mangone M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prostaglandin D2 metabolite is elevated in the urine of Duchenne muscular dystrophy patients and increases further from 8 years old.
    Nakagawa T; Takeuchi A; Kakiuchi R; Lee T; Yagi M; Awano H; Iijima K; Takeshima Y; Urade Y; Matsuo M
    Clin Chim Acta; 2013 Aug; 423():10-4. PubMed ID: 23603101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mutation-specific treatments for Duchenne muscular dystrophy].
    Matsuo M; Takeshima Y
    Brain Nerve; 2009 Aug; 61(8):915-22. PubMed ID: 19697880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic
    Wong TWY; Ahmed A; Yang G; Maino E; Steiman S; Hyatt E; Chan P; Lindsay K; Wong N; Golebiowski D; Schneider J; Delgado-Olguín P; Ivakine EA; Cohn RD
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32988972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients.
    Hofstra RM; Mulder IM; Vossen R; de Koning-Gans PA; Kraak M; Ginjaar IB; van der Hout AH; Bakker E; Buys CH; van Ommen GJ; van Essen AJ; den Dunnen JT
    Hum Mutat; 2004 Jan; 23(1):57-66. PubMed ID: 14695533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
    Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S
    Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic Injection of Peptide-PMOs into Humanized DMD Mice and Evaluation by RT-PCR and ELISA.
    Melo D; Maruyama R; Yokota T
    Methods Mol Biol; 2018; 1828():263-273. PubMed ID: 30171547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Molecular therapies for Duchenne muscular dystrophy].
    Takeshima Y
    No To Hattatsu; 2016 Jul; 48(4):241-6. PubMed ID: 30010301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.